Sodium-glucose cotransporter-2 inhibitors, and glucagon-like peptide-1 receptor agonists, and the risk of macrovascular, and microvascular complications among patients with type 2 diabetes and non-alcoholic fatty liver disease

被引：0
|
作者：
Bea, Sungho [1 ]
Filion, Kristian B. [2 ]
Shin, Ju-Young [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea
[2] McGill Univ, Montreal, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
58
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [11] Efficacy of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on proteinuria and weight in a diabetes cohort
    Lu, Di-Fei
    Zheng, Rui
    Li, Ang
    Zhang, Jun-Qing
    WORLD JOURNAL OF DIABETES, 2025, 16 (02)
  • [12] Comparative effectiveness of insulin glargine, glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in veterans with type 2 diabetes
    Shen, Jincheng
    Sarwal, Amara
    Singh, Ravinder
    Hartsell, Sydney E.
    Wei, Guo
    Nevers, Mckenna
    Christensen, Jesse C.
    Takyi, Augustine
    Katkam, Niharika
    Derington, Catherine G.
    Deshmukh, Vikrant G.
    Boucher, Robert E.
    Drakos, Stavros G.
    Greene, Tom
    Beddhu, Srinivasan
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2120 - 2130
  • [13] Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists
    Kintzoglanakis, Kyriakos
    Diamantis, Christos
    Mariolis, Anargiros
    Paschou, Stavroula A.
    DIABETES & VASCULAR DISEASE RESEARCH, 2024, 21 (04):
  • [14] Review of cardiovascular outcomes trials of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists
    North, Emily J.
    Newman, Jonathan D.
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (06) : 687 - 692
  • [15] Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes
    Ikonomidis, Ignatios
    Pavlidis, George
    Pliouta, Loukia
    Katogiannis, Konstantinos
    Maratou, Eirini
    Thymis, John
    Michalopoulou, Eleni
    Prentza, Vasiliki
    Katsanaki, Eleni
    Vlachomitros, Dimitrios
    Kountouri, Aikaterini
    Korakas, Emmanouil
    Andreadou, Ioanna
    Kouretas, Dimitrios
    Parissis, John
    Lambadiari, Vaia
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (05):
  • [16] A META-ANALYSIS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Wong, Chloe
    Yaow, Clyve Yu Leon
    Lee, Ming Hui
    Chin, Yip Han
    Ng, Cheng Han
    Khoo, Chin Meng
    Muthiah, Mark Dhinesh
    GASTROENTEROLOGY, 2021, 160 (06) : S839 - S840
  • [17] New Diabetes Guidelines: Impact on Eligibility for Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Canada
    Bodoarca, Rebecca
    Yeung, Roseanne O.
    Lau, Darren
    CANADIAN JOURNAL OF DIABETES, 2022, 46 (07) : 691 - 698
  • [18] DEMOGRAPHIC AND CLINICAL PROFILES OF PATIENTS WITH TYPE 2 DIABETES NEWLY INITIATING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS COMPARED TO GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
    Pineda, E.
    Liao, I. C.
    Godley, P. J.
    Michel, J.
    Rascati, K.
    VALUE IN HEALTH, 2019, 22 : S152 - S152
  • [19] Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes
    Pradhan, Richeek
    Yin, Hui
    Lu, Sally
    Sebastiani, Giada
    Yu, Oriana
    Suissa, Samy
    Azoulay, Laurent
    DIABETES CARE, 2025, 48 (03)
  • [20] Weight loss differences seen between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for treatment of type 2 diabetes
    Frieling, Katherine
    V. Monte, Scott
    Jacobs, David
    Albanese, Nicole Paolini
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2021, 61 (06) : 772 - 777
12345